Here is the summary: **Financial Highlights:** Sharda Cropchem reported a strong Q1 FY26, with total revenue up 25% to ₹985 Cr.

Agrochemical segment revenue grew 25% to ₹846 Cr, and non-agrochemicals rose 31% to ₹139 Cr.

Gross margins expanded significantly by 630 basis points to 35.5%. EBITDA surged 67% to ₹142 Cr, and Profit After Tax (PAT) soared 424% to ₹143 Cr.

The company reduced working capital by 18 days, maintaining a strong balance sheet. **Strategic Initiatives & Growth Drivers:** The company operates on an asset-light business model, focusing on intellectual property and registrations.

It boasts 2,981 procured registrations and 1,021 applications pending globally.

Key strategies include forward integration by building a stronger sales force, expanding and strengthening distribution presence, and continued investment in product registrations for generic molecules.

CAPEX incurred in Q1 FY26 was ₹114 Cr. **Business Developments:** Sharda Cropchem continues to expand its global footprint, now present in over 80 countries with 525 third-party distributors and a growing sales force of 500+. The company has successfully adopted a "factory-to-farmer" approach, aiming to be a one-stop solution provider. **Market Position & Competitive Advantage:** As an IP-driven company, Sharda Cropchem holds a strong position in the generic crop protection chemicals industry, especially in Advanced Markets like Europe, North America, and Latin America, leveraging its extensive dossier library for diversified product offerings. **Investor Implications:** The robust Q1 FY26 performance, marked by significant revenue and profit growth alongside margin expansion, indicates positive growth potential.

The strategic focus on global market penetration, asset-light model, and continuous investment in registrations positions the company for sustained long-term growth.